Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Kasus

Download as pdf or txt
Download as pdf or txt
You are on page 1of 38

Kasus:

• Seorang ♀ 55 thn dtg ke poli dgn BAK sering tp tidak puas. Seblmnya
psn mengeluhkan hal yang sama kemudian sembuh. DM (+) 7 thn
• Vital sign : Sens : CM, TD: 120/70 mmHg, nadi: 70 x/i, pernafasan:
18x/I , suhu : 36,8⁰C,
• Pemeriksaan fisik : nyeri tekan suprapubik
• Pertanyaan :
1. Apakah kemungkinan diagnosa pada pasien ini?
2. Pemeriksaan penunjang apa yang diperlukan untuk membuktikan
diagnosa sementara pada pasien tersebut?
3. Jelaskan pengelolaan pada pasien ini ?
Division of Nephrology and Hypertension, Department of
Internal Medicine, Faculty of Medicine,
Universitas Sumatera Utara
Definition UTI

Is a broad term used to described microbial


contamination of the urine and infection of
the structure of the urinary tract

The infection process may involve kidney,


renal pelvis, ureters, bladder, and urethra
Lower Urinary Tract Infection

Cystitis

Prostatitis

Urethritis
Epidemiology

The risk of UTI in women 10x men.. Why? the shorter distance between anus and meatus urethrae
externum.
• ~2% incidence in preschool children females
• ~5% of school-aged females
• Large majority of adult cases are females - 30:1
• Forty percent of all females have at least one episode of a UTI at some time in their lives.
• The risk of UTI in women increases after menopause
Women generally don't have many problems with UTI's until they become sexually active.
Postmenopausal:
bladder or uterine prolapse
loss of estrogen that causes a change in the vaginal flora
loss of lactobacilli in the vaginal flora which results in periurethral colonization
UTI in men

Males experience a rapid increase in the incidence UTI's sometime in their 50’s -
benign prostatic hypertrophy
a UTI in men can be associated with either acute or chronic bacterial prostatitis
prostatitis or epididymitis may play a part particularly in febrile UTI
it is advisable to palpate both the prostate and scrotum
chronic bacterial prostatitis, or at least the retention of bacteria in the prostatic
ducts, should be suspected in relapses with the same causative bacteria
UTIs in men (2)
Afebrile lower urinary tract infection in men:
🡪if the infection is not associated with urinary stricture or prostatitis,it is
treated with the same drugs as cystitis in women, but the treatment should
continue for 7 - 10 days
🡪nitrofurantoin should not be used in men as adequate prostatic
concentrations are not achieved (D)

Febrile urinary tract infection in men is treated with


🡪a long course of antibiotics with good prostatic and epididymal penetration
🡪first choice: a fluoroquinolone for 2 weeks
UTIs in men (3)
UTI in men associated with acute bacterial prostatitis
treatment for 4 - 6 weeks (depending how quickly patient responds to
treatment
to be followed up with low dose prophylaxis with e.g. trimethoprim or
nitrofurantoin

Chronic bacterial prostatitis


🡪 recurrent UTI’s and calcifications in prostate
oral quinolones for 2 – 3 months (D)
to be followed up with prophylactic medication
Nicole LE .UTI In Lerma EV et al Eds .Nephrology Secrets, Fourth Edition,
Elsevier 2019
Pathogenese UTI
Lower UTI:
Dysuria
frequency
Lower UTI Diagnostic Algorithm
Prostatitis

Trauma
Risk Factor Sexual abstinence
Dehydration

Pain in the perineum, lower abdomen, testicles,


penis, and with ejaculation, bladder irritation,
Diagnosis
bladder outlet obstruction, and sometimes blood in
the semen

Treatment Trimethoprim/sulfamethoxazole, fluroquinolone


or other broad spectrum antibiotic
4-6 weeks of treatment
Urethritis

Chlamydia trachomatis

Frequently asymptomatic in females, but can present with dysuria,


discharge or pelvic inflammatory disease.
Do urine culture (if pyuria seen, but no bacteria, suspect chlamydia)
Pelvic exam – send discharge from cervical or urethral for chlamydia PCR
Chlamydia screening is now recommended for all females ≤ 25 years
Treatment:
Azithromycin – 1 g po x 1
Doxycycline – 100 mg po BID x 7 days
Neisseria gonorrhoeae

May present with dysuria, discharge, PID


Do urine culture
Pelvic exam – send discharge samples for gram stain, culture, PCR
Treatment:
- Ceftriaxone – 125 mg IM x 1
- Cipro – 500 mg po x 1
- Levofloxacin – 250 mg po x 1
- Ofloxacin – 400 mg po x 1
- Spectinomycin – 2 g IM x 1
You should always also treat for chlamydia when treating for gonnorhea!
Cystitis

Infection of the urinary tract limited to the bladder, usually


Definition involving only the mucosal surface.
Most common type of UTI in the long-term care setting

Uncomplicated Cystitis

Classification Complicated Cystitis

Recurrent Cystitis
Uncomplicated (Simple ) Cystitis

🡪 Sexual intercourse
Risk Factor → May recommend post-coital voiding or prophylactic
antibiotic use.

• Healthy adult woman (over age 12)


• Non-pregnant
Symptoms
• No fever, nausea, vomiting, flank pain

• if the symptoms are atypical, a strip test urinalysis may be carried out to
support diagnosis (no culture or lab tests needed)
Diagnosis • If the strip test is negative, the urine should be cultured and other reasons
for the symptoms should be considered

Patient with typical symptoms, not belonging to any of the risk groups, is
treated without laboratory investigations
Treatment 🡪 Trimethroprim/Sulfamethoxazole for 3-5 days
May use fluoroquinolone (ciprofoxacin or levofloxacin) in patient with
sulfa allergy, areas with high rates of bactrim-resistance
Antimicrobial management of acute uncomplicated cystitis

Adapted from Hooton, T.M. Clinical practice. Uncomplicated UTI. NEJM 2012 366, 1028–1037.
Table 1. Antimicrobial in uncomplicated lower urinary tract

Antimicrobial dose Duration of treatment

Trimetoprim-Sulfamethoxazole 160/800 mg q12h 3 days


Trimetoprim 100 mg q12h 3 days
ciproflokxacin 100-250 mg q12h 3 days
Levofloxacin 250 mg q12h 3 days
cefixime 400 mg q 24h 3 days
Cefpodoxime proksetil 100 mg q12h 3 days
Nitrofurantoin macrocrystal 50 mg q6h 7 days
Nitrofurantoin monohidrat 100 mg q12h 7 days
macrocrystal
Amoxicillin/clavulanat 500 mg q 12 hr 7 days
Complicated Cystitis

Females with comorbid medical conditions


All male patients
Risk Factor
Indwelling foley catheters
Urosepsis/hospitalization

Urinalysis, Urine culture


Diagnosis Further labs, if appropriate

Fluoroquinolone (or other broad spectrum antibiotic)


Treatment 7-14 days of treatment (depending on severity)
May treat even longer (2-4 weeks) in males with UTI
Reccurent Cystitis

Want to make sure urine culture and


sensitivity obtained.
Diagnosis May consider urologic work-up to
evaluate for anatomical abnormality.

Treatment Treat for 7-14 days


Prophylaxis of recurrent cystitis with antimicrobial agents

• prophylaxis should be considered when more than 3


infections per year
• prophylaxis to continue for 6 months
• if infections recur after prophylactic treatment, the
prophylaxis is re-commenced for 6 – 12 months (D)
Drugs of choice in UTI prophylaxis
First choice:
• trimethoprim 100 mg in the evenings
• nitrofurantoin 50 - 75 mg in the evenings
Second choice:
• methenamine hippurate 1 g twice daily
• norfloxacin 200 mg daily or on 3 evenings per week
• nitrofurantoin (not if serum creatinine is above 150 μmol/l)
• quinolones (in cases where there is no response with other prophylactic
medication or tolerance to other medications is poor)
During pregnancy:
• nitrofurantoin 50 mg daily or
• methenamine hippurate 1 g daily for the rest of the pregnancy
• particularly if recurrent bacteriuria is diagnosed in early pregnancy
Medication to be taken after intercourse

A single-dose prophylaxis taken after intercourse is effective in women whose


UTI’s are clearly associated with sexual intercourse (A)

• First choice:
– trimethoprim 100-300 mg as a single dose
– nitrofurantoin 50-75 mg as a single dose
• Second choice:
– norfloxacin 200 mg, ofloxacin 100 mg or ciprofloxacin 100-250 mg
– sulphatrimethoprim (1 single-strength tablet)
Lower UTIs in children

• treatment principles are the same as for adults


• little evidence to support short term treatment in
children (C)
• drugs of choice
– nitrofurantoin 5 mg/kg/day or
– trimethoprim 8 mg/kg/day
– treatment to continue for 5 days (C)
Probable lower UTI with generalised symptoms in children

• treated so that any possible infection of the kidney is also covered,


i.e. with antibiotics with high tissue penetrability
• oral medication acceptable
• drugs of choice
– sulphatrimethoprim (trimethoprim 8 mg/kg/day)
– cefalexin 30 - 50 mg/kg/day in 3 divided doses
– cefuroxime axetil 20 mg/kg/day in 2 divided doses or
– mecillinam 20 - 40 mg/kg/day in 3 divided doses
– treatment to continue for 7 days (C)
The main quality criteria for the treatment of UTI’s

• urine sample to be collected appropriately when infection is suspected


• unnecessary culturing of urine samples to be avoided
• the investigation and treatment of asymptomatic bacteriuria to be
reserved for risk groups
• diagnosing structural anomalies of the urinary tract in children
• rational use of antibiotics
Antimicrobial therapy in UTI

Reserve drugs:
• Quinolones (norfloxacin, ofloxacin or ciprofloxacin) for 3 days
– if first choice drugs are not suitable or
– if the infection has not responded to first choice drugs or
– recurrent infection within 4 weeks
– if there is a relapse, urine must be cultured and the treatment should be continued for 7
days
• In special cases:
– cefalexin or cefadroxil for 5 days (if the above are contraindicated)
– sulphatrimethoprim (SMZ-TM) for 3 days (particularly if the level of infection is unclear)
– amoxicillin for 5 days (particularly in enterococcal infections)
Single-dose therapy

• single-dose therapy is slightly less effective than conventional therapy


• effective in infections caused by E. coli, but less so in S. saprophyticus infections
• recommended particularly when practical reasons warrant its use (e.g. self-care)
• Preparations:
– phosphomycin 3 g
– norfloxacin 800 mg
– ciprofloxacin 500 - 750 mg
– ofloxacin 200 mg as a single dose
Antimicrobial therapy in association with a urinary catheter

• the treatment of UTI in a catheterised patient should always be based on the


identity and sensitivity of the causative microbe
• the catheter should always be removed, at least for the duration of treatment,
as otherwise the bacteria will not be eradicated
• if this is not feasible, the recommendation is to continue treatment for 7 - 10
days even in lower UTI’s
Antimicrobial therapy in association with a urinary catheter

In the following patient groups antibiotics can prevent serious infective complications caused by
long-term catheterisation :
• after renal transplant (for 3 months)
• granulocytopenic patients and possibly in diabetics
• it is recommended that drugs which could be of benefit in serious infections (beta-lactamases and
fluoroquinolones) are not used for prophylaxis

Antibiotic prophylaxis is not recommended:


• for repeat catheterisations

• for the insertion of long-term catheter

• for pyuria and bacteriuria in a patient with a long-term catheter but no obvious infection
Antimicrobial therapy in association with a urinary catheter

Fungal bladder infection in a catheterised patient:


• systemic fluconazole is slightly more effective than topical amphotericin B
• removal of the catheter will improve the eradication of the microbe during
therapy

Suprapubic catheter:
• its use is associated with a lower incidence of bacteriuria in postoperative care
• any infections are treated as any other infections associated with urinary
catheters
Follow-up after Uncomplicated Cystitis or Pyelonephritis

• a urine culture is unnecessary if symptoms have resolved, except in pregnant women


(for whom treatment of persistent asymptomatic bacteriuria is recommended)
• In women with recurrent uncomplicated cystitis or pyelonephritis, routine urologic
evaluation (with the use of ultrasonography or computed tomography) has a low
diagnostic yield and is not recommended.
• However,it should be considered in women who have persistent hematuria or
multiple early recurrences of cystitis involving the same strain of bacteria.
• In women with pyelonephritis who have severe or worsening illness, persistent
fever 48 to 72 hours after the initiation of appropriate antimicrobial treatment, or
symptoms suggestive of a stone, abscess, or obstruction, urologic evaluation should
be performed to rule out these latter abnormalities.

• It is also reasonable to perform imaging studies in women who have two or more
recurrences of pyelonephritis
Other preventive regiments

▪ Drink sufficient fluid to void 2 ltr per day

▪ Void 2 – 3 hourly with double micturition if reflux present

▪ Avoid bubble baths and chemical additives in bath water

▪ Avoid constipation which may impair bladder emptying

36
Thank you

You might also like